Brief: EQL Pharma Says Methenamine Hippurate EQL Pharma Approved

EQL Pharma AB

06/05/2019 15:46

May 6 (Reuters) - EQL Pharma AB  EQL.TE :
    * SAYS METHENAMINE HIPPURATE EQL PHARMA APPROVED
    * PRODUCT IS EXPECTED TO BE LAUNCHED DURING Q4, 2019

Source text: https://bit.ly/2VQNmbu
Further company coverage:  EQL.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))